Subscribe via E-mail

Your email:

NeuroNews

Current Articles | RSS Feed RSS Feed

Alzheimer's Study at MidAmerica Neuroscience Institute

  
  
  

MidAmerica Neuroscience Institute in Lenexa, KS was highlighted in an investigational news piece about Alzheimer's clinical drug research.  The story featured neurologist Dana Winegarner, DO discussing the Institute's involvement and his initial impressions of the investigational drug Bapineuzumab. 
The 5- minute long video captures the hopes and fears of a 77 year old Kansas City man with Alzheimer's disease, and his wife, as one of the thousands of participants across multiple sites that involved in this clinical trial.

MidAmerica Neuroscience Institute is a comprehensive clinicalMidAmerica Neuroscience Institute neurology practice that also engages in basic science research and clincal research trials of Multiple Sclerosis, Dementia, Headaches and Sleep Disorders.
The practice has three Kansas City area locations with headquarters located at:
8550 Marshall Dr, Suite 100
Lenexa, KS 66214
913-894-1500


Comments

Currently, there are no comments. Be the first to post one!
Post Comment
Name
 *
Email
 *
Website (optional)
Comment
 *

Allowed tags: <a> link, <b> bold, <i> italics